ACCESS TO INNOVATIVE PHARMACEUTICAL DRUGS:
UNCERTAINITIES IN DRUG DEVELOPMENT – AN INNOVATION MANAGEMENT APPROACH
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: HOLBEIN, Baerbel (University of Bremen, Lilienthal, Germany)
- Co-author(s): Baerbel Holbein
The number of innovative pharmaceutical drugs getting marketed is stagnating. The R&D costs for new drugs are rising. Public healthcare systems need to ensure medication for all therapeutical areas are available and not only for particular indications. The development of innovative drugs is highly costly. It is associated with certain risks.
Therap.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.